Hypophosphatemic Effect of Niacin in Patients without Renal Failure | Zendy

Darbie Maccubbin | Zendy; Diane Tipping | Zendy; Olga Kuznetsova | Zendy; William A. Hanlon | Zendy; Andrew G. Bostom | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hypophosphatemic Effect of Niacin in Patients without Renal Failure

Author(s) -

Darbie Maccubbin,

Diane Tipping,

Olga Kuznetsova,

William A. Hanlon,

Andrew G. Bostom

Publication year - 2010

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.07341009

Subject(s) - medicine , hyperphosphatemia , niacin , dyslipidemia , endocrinology , placebo , phosphorus , post hoc analysis , confidence interval , gastroenterology , concomitant , diabetes mellitus , kidney disease , alternative medicine , pathology , materials science , metallurgy

Niacin administration lowers the marked hyperphosphatemia that is characteristic of renal failure. We examined whether niacin administration also reduces serum phosphorus concentrations in patients who have dyslipidemia and are free of advanced renal disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research